Global coronavirus infections surpassed the 75 million mark on Dec. 19, according to a Reuters tally, as several nations around the world begin vaccinating against the virus.
German biotech firm CureVac enrolled the first participant for a Phase 2b/3 clinical trial of the company’s Covid-19 vaccine candidate.
Europe’s new Covid-19 cases doubled in five weeks, propelling the region across the bleak milestone of 10 million total infections, according to a Reuters tally.
Global coronavirus cases rose by more than 500,000 for the first time, a record one-day increase as countries across the Northern Hemisphere reported daily spikes.
(Reuters) – Europe became the second region after Latin America to surpass 250,000 deaths on Saturday, according to a Reuters tally, with record numbers of daily COVID-19 infections reported in the past two weeks.
Moderna Inc. completed the enrollment of 30,000 participants in a late-stage study testing the company’s experimental coronavirus vaccine, with over a third of the participants from communities of color.
Global coronavirus cases rose by more than 400,000 for the first time, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak.
The global coronavirus death toll surpassed 1 million according to a Reuters tally, a bleak statistic in a pandemic that has devastated the global economy, overloaded health systems and turned daily life upside down.
Global coronavirus cases surged past 25 million, according to a Reuters tally, as India marked a worldwide record for daily new cases in the Covid-19 pandemic.
Mexico aims to conduct late-stage clinical trials for Covid-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said.